Literature DB >> 31064218

Advanced glycation end product carboxymethyl-lysine and risk of incident peripheral artery disease in older adults: The Cardiovascular Health Study.

Parveen K Garg1, Mary L Biggs2, Joshua Barzilay3, Luc Djousse4, Calvin Hirsch5, Joachim H Ix6, Jorge R Kizer7,8, Russell P Tracy9, Anne B Newman10, David S Siscovick11, Kenneth J Mukamal12.   

Abstract

Carboxymethyl-lysine is an advanced glycation end product that is detectable in the serum. Higher carboxymethyl-lysine levels have been associated with increased risk of coronary heart disease, stroke and cardiovascular mortality. We determined whether high carboxymethyl-lysine levels are also associated with the risk of peripheral artery disease in Cardiovascular Health Study participants who were all aged 65 years and older at baseline. Multivariate Cox proportional hazards models were used to determine the association of baseline carboxymethyl-lysine levels with incident peripheral artery disease in 3267 individuals followed for a median length of 10.0 years. A total of 157 cases of incident peripheral artery disease occurred during follow-up. No significant relationship between carboxymethyl-lysine and risk of peripheral artery disease was found (hazard ratio per standard deviation increment = 1.03; 95% confidence interval = 0.87, 1.23).

Entities:  

Keywords:  Advanced glycation end products; ankle–brachial index; inflammation; peripheral artery disease

Mesh：

Substances：

Year:  2019        PMID： 31064218      PMCID： PMC6697602          DOI： 10.1177/1479164119847481

Source DB:  PubMed          Journal:  Diab Vasc Dis Res        ISSN： 1479-1641            Impact factor:   3.291


  5 in total

1.  Skin autofluorescence as a measure of advanced glycation end products deposition is elevated in peripheral artery disease.

Authors:  Lisanne C de Vos; Marjon J Noordzij; Douwe J Mulder; Andries J Smit; Helen L Lutgers; Robin P F Dullaart; Pieter W Kamphuisen; Clark J Zeebregts; Joop D Lefrandt
Journal:  Arterioscler Thromb Vasc Biol       Date:  2012-11-08       Impact factor: 8.311

Review 2.  ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation.

Authors:  Alan T Hirsch; Ziv J Haskal; Norman R Hertzer; Curtis W Bakal; Mark A Creager; Jonathan L Halperin; Loren F Hiratzka; William R C Murphy; Jeffrey W Olin; Jules B Puschett; Kenneth A Rosenfield; David Sacks; James C Stanley; Lloyd M Taylor; Christopher J White; John White; Rodney A White; Elliott M Antman; Sidney C Smith; Cynthia D Adams; Jeffrey L Anderson; David P Faxon; Valentin Fuster; Raymond J Gibbons; Sharon A Hunt; Alice K Jacobs; Rick Nishimura; Joseph P Ornato; Richard L Page; Barbara Riegel
Journal:  Circulation       Date:  2006-03-21       Impact factor: 29.690

Review 3.  Advanced glycation end products and vascular inflammation: implications for accelerated atherosclerosis in diabetes.

Authors:  Giuseppina Basta; Ann Marie Schmidt; Raffaele De Caterina
Journal:  Cardiovasc Res       Date:  2004-09-01       Impact factor: 10.787

4.  Advanced glycation/glycoxidation endproduct carboxymethyl-lysine and incidence of coronary heart disease and stroke in older adults.

Authors:  Jorge R Kizer; David Benkeser; Alice M Arnold; Joachim H Ix; Kenneth J Mukamal; Luc Djousse; Russell P Tracy; David S Siscovick; Bruce M Psaty; Susan J Zieman
Journal:  Atherosclerosis       Date:  2014-04-30       Impact factor: 5.162

5.  Lipoprotein-Associated Phospholipase A2 and Incident Peripheral Arterial Disease in Older Adults: The Cardiovascular Health Study.

Authors:  Parveen K Garg; Alice M Arnold; Karen D Hinckley Stukovsky; Carol Koro; Nancy S Jenny; Kenneth J Mukamal; Michael H Criqui; Curt D Furberg; Anne B Newman; Mary Cushman
Journal:  Arterioscler Thromb Vasc Biol       Date:  2016-02-04       Impact factor: 8.311
  5 in total
  1 in total

1.  Correlation Analysis of CML, sRAGE, and esRAGE and the Measure of Atherosclerosis of Coronary Heart Disease.

Authors:  Wenjun Liu; Yuqiang Ji; Weiwei Zhang; Fei Fang; Qin Cai; Ying Li
Journal:  Comput Intell Neurosci       Date:  2022-06-10
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.